Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of clinically aggressive
diseases associated with poor outcome. Studies that focus specifically on PTCL are …

Non-Hodgkin lymphoma is a non-specific term that includes several lymphoproliferative
malignant diseases with different clinical and histological appearances. Here, we …

Background The efficacy of autologous stem-cell transplantation during the first remission in
patients with diffuse, aggressive non-Hodgkin's lymphoma classified as high-intermediate …

Purpose Peripheral T-cell lymphomas (PTCLs) are rare malignancies with poor outcome
after conventional chemotherapy. The role of myeloablative therapy and autologous stem …

Recognizing the significant biological and clinical heterogeneity of mature T cell and natural
killer (NK)/T cell lymphomas, the American Society for Blood and Marrow Transplantation …

Background High-dose therapy (HDT) followed by transplantation of autologous
haemopoietic stem cells is frequently done as part of first-line therapy in young patients with …

To evaluate the prognostic significance of clinicobiologic and pathological features in
angioimmunoblastic T-cell lymphoma (AITL), 157 AITL patients were retrieved from the …

The disease we now call diffuse large B-cell lymphoma has gone by many names in the
past. These have included reticulum cell sarcoma, 1 diffuse histiocytic lymphoma, 2 and …

Purpose Systemic anaplastic large-cell lymphoma (ALCL) is a T-cell lymphoma, whose
anaplastic lymphoma kinase (ALK) expression varies according to age. Long-term outcomes …

Background The efficacy of first-line intensive chemotherapy plus transplantation of
autologous hematopoietic stem cells in adults with disseminated aggressive lymphoma is …